Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 9, 2000, Pages 2276-2285

  Cui, L ^a   Murakami, H ^a   Kuwahara Arai, K ^a   Hanaki, H ^a   Hiramatsu, K ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; VANCOMYCIN;

AMIDATION; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOLYSIS; BACTERIAL CELL WALL; BACTERIAL INFECTION; BINDING AFFINITY; CROSS LINKING; ENZYME ACTIVITY; GLUCOSE UTILIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; CARBON RADIOISOTOPES; CELL WALL; CULTURE MEDIA; GLUCOSE; GLUTAMATE-AMMONIA LIGASE; GLUTAMINE; HUMANS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 0033840740     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.9.2276-2285.2000     Document Type: Article

References (34)

1. Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus
2. Active site-directed inactivation of Escherichia coli glucosamine-6-phosphate synthase. Determination of the fructose 6-phosphate binding constant using a carbohydrate-based inactivator
3. Bacillus subtilis glutamine synthetase mutants pleiotropically altered in glucose catabolite repression
4. Glucosamine metabolism. V. Enzymatic synthesis of glucosamine-6-phosphate
5. The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon
6. Genetics of amino acid transport in bacteria
7. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus Clinical strains Mu3 and Mu50
8. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50
9. Evaluation of reduced vancomycin susceptibility of MRSA strain Mu50 with various conditions of antibiotic susceptibility test
10. Pathway choice in glutamate synthesis in Escherichia coli
11. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
12. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
13. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
14. Vancomycin resistance in Staphylococci
15. Mechanisms of methicillin and vancomycin resistance in Staphylococcus aureus
16. Glycopeptide resistance in staphylococci
17. Genetic basis for the molecular epidemiology of MRSA
18. Regulation of glucosamine utilization in Staphylococcus aureus and Escherichia coli
19. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method
20. Amidation and cross-linking of the enzymatically synthesized peptidoglycan of Bacillus stearothermophilus
21. Wall peptidoglycan in Aerococcus viridans strains 201 Evans and ATCC 11563 and in Gaffkya homari strain ATCC 10400
22. Assembly and polymerization: The bacterial interior
23. The peptidoglycan composition of a Staphylococcus aureus mutant selected for reduced methicillin resistance
24. Improved tools for biological sequence comparison
25. Co-ordinated regulation of amino sugar biosynthesis and degradation: The NagC repressor acts as both an activator and a repressor for the transcription of the glmUS operon and requires two separated NagC binding sites
26. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics
27. Nutritional requirements for bacterial cell wall synthesis
28. Biosynthesis of the peptidoglycan of bacterial cell walls. XI. Formation of the isoglutamine amide group in the cell walls of Staphylococcus aureus
29. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
30. Glutamine synthetase and heteroresistance in methicillin-resistant Staphylococcus aureus
31. In-vitro activity of DU-6859a against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibilities to vancomycin
32. Characterization of staphylococci width reduced susceptibilities to vancomycin and other glycopeptides
33. Regulation of bacterial cell walls: Turnover of cell wall in Staphylococcus aureus
34. Glucosamine-6-phosphate synthase